145 related articles for article (PubMed ID: 27935998)
21. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
22. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.
Zhang MJ; Sansbury BE; Hellmann J; Baker JF; Guo L; Parmer CM; Prenner JC; Conklin DJ; Bhatnagar A; Creager MA; Spite M
Circulation; 2016 Aug; 134(9):666-680. PubMed ID: 27507404
[TBL] [Abstract][Full Text] [Related]
23. Resolvin D2 attenuates LPS-induced macrophage exhaustion.
Padovani CM; Wilson RM; Rodriguez A; Spur BW; Yin K
FASEB J; 2024 Apr; 38(7):e23569. PubMed ID: 38551610
[TBL] [Abstract][Full Text] [Related]
24. Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes.
Gu Z; Lamont GJ; Lamont RJ; Uriarte SM; Wang H; Scott DA
Innate Immun; 2016 Apr; 22(3):186-95. PubMed ID: 26878867
[TBL] [Abstract][Full Text] [Related]
25. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody.
Underwood DC; Osborn RR; Newsholme SJ; Torphy TJ; Hay DW
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):850-7. PubMed ID: 8887574
[TBL] [Abstract][Full Text] [Related]
26. Effects of mitogen-activated protein kinase kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro.
Tsang F; Koh AH; Ting WL; Wong PT; Wong WS
Br J Pharmacol; 1998 Sep; 125(1):61-8. PubMed ID: 9776345
[TBL] [Abstract][Full Text] [Related]
27. Role of Protein Tyrosine Phosphatase Epsilon (PTP
Lapointe F; Turcotte S; Véronneau S; Rola-Pleszczynski M; Stankova J
J Pharmacol Exp Ther; 2019 May; 369(2):270-281. PubMed ID: 30867226
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of the cysteinyl-leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro.
Capra V; Bolla M; Belloni PA; Mezzetti M; Folco GC; Nicosia S; Rovati GE
Br J Pharmacol; 1998 Feb; 123(3):590-8. PubMed ID: 9504401
[TBL] [Abstract][Full Text] [Related]
29. Cysteinyl-maresin 3 inhibits IL-13 induced airway hyperresponsiveness through alternative activation of the CysLT
Säfholm J; Abma W; Bankova LG; Boyce JA; Al-Ameri M; Orre AC; Wheelock CE; Dahlén SE; Adner M
Eur J Pharmacol; 2022 Nov; 934():175257. PubMed ID: 36116518
[TBL] [Abstract][Full Text] [Related]
30. EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17.
Morin C; Sirois M; Echave V; Gomes MM; Rousseau E
Am J Respir Cell Mol Biol; 2008 Feb; 38(2):192-201. PubMed ID: 17872494
[TBL] [Abstract][Full Text] [Related]
31. CPI-17 silencing-reduced responsiveness in control and TNF-alpha-treated human bronchi.
Morin C; Sirois M; Echave V; Rousseau E
Am J Respir Cell Mol Biol; 2008 Dec; 39(6):638-43. PubMed ID: 18757304
[TBL] [Abstract][Full Text] [Related]
32. Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis.
Mizraji G; Heyman O; Van Dyke TE; Wilensky A
Front Immunol; 2018; 9():785. PubMed ID: 29922275
[TBL] [Abstract][Full Text] [Related]
33. Leukotriene D4 contractions in human airways are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry.
Gorenne I; Labat C; Gascard JP; Norel X; Nashashibi N; Brink C
J Pharmacol Exp Ther; 1998 Feb; 284(2):549-52. PubMed ID: 9454796
[TBL] [Abstract][Full Text] [Related]
34. Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-κB, p38 and JNK.
Daniele S; Da Pozzo E; Zappelli E; Martini C
Cell Signal; 2015 Aug; 27(8):1609-29. PubMed ID: 25911310
[TBL] [Abstract][Full Text] [Related]
35. Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery.
Hiram R; Rizcallah E; Sirois C; Sirois M; Morin C; Fortin S; Rousseau E
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1547-58. PubMed ID: 25281570
[TBL] [Abstract][Full Text] [Related]
36. Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis.
Gyllfors P; Kumlin M; Dahlén SE; Gaber F; Ehrs PO; Dahlén B
Thorax; 2005 Nov; 60(11):902-8. PubMed ID: 16055619
[TBL] [Abstract][Full Text] [Related]
37. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
Pope NH; Salmon M; Davis JP; Chatterjee A; Su G; Conte MS; Ailawadi G; Upchurch GR
FASEB J; 2016 Dec; 30(12):4192-4201. PubMed ID: 27619672
[TBL] [Abstract][Full Text] [Related]
38. Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma.
Rovati GE; Baroffio M; Citro S; Brichetto L; Ravasi S; Milanese M; Crimi E; Brusasco V
Respir Res; 2006 Jul; 7(1):103. PubMed ID: 16875498
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
Ferrari F; Mennuni L; Caselli G; Zanelli T; Makovec F
Eur J Pharmacol; 2004 Nov; 504(3):223-33. PubMed ID: 15541426
[TBL] [Abstract][Full Text] [Related]
40. Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons.
Wang XY; Tang SS; Hu M; Long Y; Li YQ; Liao MX; Ji H; Hong H
Neurochem Int; 2013 Feb; 62(3):340-7. PubMed ID: 23318673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
